Nu Skin Enterprises, Inc. (NUS) stock
NUSNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 12/3069% below fair value
$3.78−0.15 (-3.82%)
Close on Nov 17, 2026Market cap $184.00MP/E –Yield –
Nu Skin Enterprises operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Nu Skin Enterprises's operating cash flow for the twelve months ending Sep 30, 2026 was $15.21M, down 83.0% year over year. For fiscal 2025 it was $80.29M, down 28.2% from the year before. Over ten years it grew -13.0% a year on average. The highest annual figure on record is $530.18M in fiscal 2013.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $80.29M | -28.2% |
| FY2024 | Dec 31, 2024 | $111.74M | -5.8% |
| FY2023 | Dec 31, 2023 | $118.64M | +9.8% |
| FY2022 | Dec 31, 2022 | $108.06M | -23.7% |
| FY2021 | Dec 31, 2021 | $141.58M | -62.7% |
| FY2020 | Dec 31, 2020 | $379.14M | +113.1% |
| FY2019 | Dec 31, 2019 | $177.93M | -12.2% |
| FY2018 | Dec 31, 2018 | $202.74M | -33.0% |
| FY2017 | Dec 31, 2017 | $302.56M | +9.9% |
| FY2016 | Dec 31, 2016 | $275.26M | -14.5% |
| FY2015 | Dec 31, 2015 | $322.11M | – |
| FY2014 | Dec 31, 2014 | -$56.46M | -110.7% |
| FY2013 | Dec 31, 2013 | $530.18M | +70.5% |
| FY2012 | Dec 31, 2012 | $310.98M | +38.6% |
| FY2011 | Dec 31, 2011 | $224.32M | +19.4% |
| FY2010 | Dec 31, 2010 | $187.88M | +40.3% |
| FY2009 | Dec 31, 2009 | $133.94M | +29.7% |
| FY2008 | Dec 31, 2008 | $103.31M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$8.12M | -129.6% |
| Q2 FY2026 | Jun 30, 2026 | $10.63M | -70.3% |
| Q1 FY2026 | Mar 31, 2026 | -$3.92M | -1107.5% |
| Q4 FY2025 | Dec 31, 2025 | $16.62M | -35.5% |
| Q3 FY2025 | Sep 30, 2025 | $27.48M | -12.6% |
| Q2 FY2025 | Jun 30, 2025 | $35.80M | -30.1% |
| Q1 FY2025 | Mar 31, 2025 | $389.00K | -88.3% |
| Q4 FY2024 | Dec 31, 2024 | $25.79M | -52.4% |
| Q3 FY2024 | Sep 30, 2024 | $31.43M | -38.4% |
| Q2 FY2024 | Jun 30, 2024 | $51.21M | +44.2% |
| Q1 FY2024 | Mar 31, 2024 | $3.32M | – |
| Q4 FY2023 | Dec 31, 2023 | $54.17M | +112.2% |
| Q3 FY2023 | Sep 30, 2023 | $51.03M | +79.4% |
| Q2 FY2023 | Jun 30, 2023 | $35.52M | -23.7% |
| Q1 FY2023 | Mar 31, 2023 | -$22.08M | -392.8% |
| Q4 FY2022 | Dec 31, 2022 | $25.53M | -76.7% |
| Q3 FY2022 | Sep 30, 2022 | $28.44M | -5.9% |
| Q2 FY2022 | Jun 30, 2022 | $46.56M | +124.7% |
| Q1 FY2022 | Mar 31, 2022 | $7.54M | – |
| Q4 FY2021 | Dec 31, 2021 | $109.51M | +15.6% |
| Q3 FY2021 | Sep 30, 2021 | $30.21M | -74.5% |
| Q2 FY2021 | Jun 30, 2021 | $20.72M | -78.7% |
| Q1 FY2021 | Mar 31, 2021 | -$18.86M | -127.3% |
| Q4 FY2020 | Dec 31, 2020 | $94.69M | +89.8% |
| Q3 FY2020 | Sep 30, 2020 | $118.37M | +121.0% |
| Q2 FY2020 | Jun 30, 2020 | $97.05M | +17.4% |
| Q1 FY2020 | Mar 31, 2020 | $69.03M | – |
| Q4 FY2019 | Dec 31, 2019 | $49.90M | -43.9% |
| Q3 FY2019 | Sep 30, 2019 | $53.55M | -13.5% |
| Q2 FY2019 | Jun 30, 2019 | $82.66M | +55.8% |
| Q1 FY2019 | Mar 31, 2019 | -$8.19M | – |
| Q4 FY2018 | Dec 31, 2018 | $88.89M | -39.4% |
| Q3 FY2018 | Sep 30, 2018 | $61.92M | -13.7% |
| Q2 FY2018 | Jun 30, 2018 | $53.05M | -15.4% |
| Q1 FY2018 | Mar 31, 2018 | -$1.11M | -105.2% |
| Q4 FY2017 | Dec 31, 2017 | $146.75M | +63.4% |
| Q3 FY2017 | Sep 30, 2017 | $71.78M | – |
| Q2 FY2017 | Jun 30, 2017 | $62.70M | – |
| Q1 FY2017 | Mar 31, 2017 | $21.33M | – |
| Q4 FY2016 | Dec 31, 2016 | $89.83M | – |
See a number that looks wrong?